AIM
NTUS

Acrospire Investment Management’s Natus Medical Inc NTUS Stock Holding History

Acrospire Investment Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-479
Closed -$18K – 1651
2017
Q2 		$18K Sell
479
-2,000
-81% -$72.2K 0.02% 1593
2017
Q1 		$97K Sell
2,479
-3,800
-61% -$143K 0.08% 339
2016
Q4 		$219K Buy
6,279
+3,935
+168% +$154K 0.09% 308
2016
Q3 		$92K Sell
2,344
-500
-18% -$19.9K 0.06% 625
2016
Q2 		$108K Buy
2,844
+800
+39% +$26.8K 0.08% 389
2016
Q1 		$79K Buy
+2,044
New +$76.1K 0.05% 518

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

Acrospire Investment Management's NTUS Position: Q3 2017 in Review

Acrospire Investment Management sold out of Natus Medical Inc (NTUS) in Q3 2017, closing a stake of 479 shares — an estimated $18K sold.

Acrospire Investment Management first reported a position in NTUS in Q1 2016 and held it in 6 quarters. The position peaked at $219K in Q4 2016. 198 funds tracked by Wall St. Rank hold NTUS as of Q3 2017.

  • Acrospire Investment Management reported no remaining Natus Medical Inc position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 479 Natus Medical Inc shares in Q3 2017, an estimated $18K.
  • Acrospire Investment Management first reported a position in Natus Medical Inc in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Natus Medical Inc position peaked at $219K in Q4 2016.
  • 198 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.